Patent · US Expired

Piperidine/piperazine-type inhibitors of p38 kinase

US6696443B2 · kind B2 · utility

9Cited by
1References
54Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 2001
Grant dateFeb 24, 2004
Priority date
Expiry dateNov 20, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain compounds which contain a piperidine moiety flanked by aryl groups are inhibitors of p38-&agr; kinase and thus useful in the treatment of a variety of conditions characterized by inappropriate p38-&agr; kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.